You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CIN 2/3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Intraepithelial Neoplasia, Cervical Dysplasia Trial in New Haven (9-valent HPV vaccine, Imiquimod)

Active, not recruiting
  • Cervical Intraepithelial Neoplasia
  • Cervical Dysplasia
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 5, 2022

Magnetic Resonance Imaging Examination Trial in Wenzhou (MRI,SCC-Ag)

Recruiting
  • Magnetic Resonance Imaging Examination
  • MRI,SCC-Ag
  • Wenzhou, Zhejiang, China
    The 2nd Affiliated Hospital and Yuying Children's Hospital of WM
Aug 3, 2022

Cervix Uteri SIL, HPV, CIN2 Trial in Prague (Colposcopy)

Recruiting
  • Cervix Uteri SIL
  • +3 more
  • Colposcopy
  • Prague, Czechia
    General University Hospital
Nov 24, 2023

CIN 2/3, HIV Trial in Lilongwe (Intravaginal 5-Fluorouracil (5-FU))

Not yet recruiting
  • CIN 2/3
  • HIV Infections
  • Intravaginal 5-Fluorouracil (5-FU)
  • Lilongwe, Malawi
    UNC Project, Kamuzu Central Hospital
Jan 17, 2023

Human Immunodeficiency Virus, HPV Infection, CIN 2/3 Trial in Kisumu (Thermocoagulation)

Completed
Has Results
  • Human Immunodeficiency Virus
  • +2 more
  • Thermocoagulation
  • Kisumu, Kenya
    Kenya Medical Research Institute
Jan 5, 2023

Cervical Cancer, Genital Warts Trial (Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine, Matching Placebo)

Active, not recruiting
Has Results
  • Cervical Cancer
  • Genital Warts
  • Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine
  • Matching Placebo
  • (no location specified)
Aug 22, 2022

Cervical Cancer, CIN2, CIN3 Trial in Westdene (5 Fluorouracil (5 FU) Cream, Placebo)

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • 5 Fluorouracil (5 FU) Cream
  • Placebo
  • Westdene, Johannesburg, South Africa
    Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
Nov 30, 2022

Cervical Intraepithelial Neoplasia Grade 2/3, High-risk HPV (Any Strain) Trial in Baltimore, Towson (Artesunate Suppositories)

Completed
Has Results
  • Cervical Intraepithelial Neoplasia Grade 2/3
  • High-risk HPV (Any Strain)
  • Artesunate Suppositories
  • Baltimore, Maryland
  • +2 more
Apr 6, 2021

Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine

Not yet recruiting
  • Cervical Cancer
  • +11 more
  • Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
  • Placebo
  • (no location specified)
Oct 17, 2022

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022

    HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)

    Recruiting
    • HPV Infections
    • +14 more
    • 9-valent HPV vaccine
    • Hangzhou, China
      Huakun Lv
    Feb 23, 2022

    HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

    Completed
    • HPV Infections
    • +14 more
    • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
    • Active Comparator: GARDASIL ®9
    • Guangxi, China
      Guangxi Zhuang Autonomous Region Center for Disease Control and
    May 9, 2022

    Cervical Cancer, CIN2, CIN3 Trial in Westdene (Urine HPV testing, Self-collected cervicovaginal specimen, Provider-collected

    Not yet recruiting
    • Cervical Cancer
    • +2 more
    • Urine HPV testing
    • +2 more
    • Westdene, Johannesburg, South Africa
      Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
    Sep 14, 2022

    HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among

    Recruiting
    • HPV Infections
    • +6 more
    • 2-doses Group among 9-14 years
    • +2 more
    • Mianyang, Sichuan, China
      Center for Disease Control and Prevention
    Feb 23, 2022

    Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,

    Recruiting
    • Cervical Cancer
    • +13 more
    • 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
    • GARDASIL®
    • Rongan County, Guangxi Zhuang Autonomous Region, China
      Rongan County Center for Disease Control and Prevention
    Feb 20, 2022

    Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion Trial in Los Angeles, Oklahoma City

    Recruiting
    • Cervical Squamous Cell Carcinoma In Situ
    • Vulvar High Grade Squamous Intraepithelial Lesion
    • Los Angeles, California
    • +1 more
    Aug 19, 2022

    Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)

    Completed
    • Cervical Cancer
    • +13 more
    • 4-valent HPV Vaccine
    • +2 more
    • Yangchun, Guangdong, China
      Yangchun Center For Disease Prevention And Control
    Feb 23, 2022

    HPV Infection, CIN 2/3, Cervical Cancer Trial in Stockholm (Gardasil9)

    Recruiting
    • HPV Infection
    • +2 more
    • Gardasil9
    • Stockholm, Sweden
      Cancer prevention, screening, and counseling unit, Regional Canc
    Sep 9, 2021

    Cervical High Grade Squamous Intraepithelial Lesion, Cervical Intraepithelial Neoplasia Grade 2/3, CIN 2/3 Trial in Netherlands

    Recruiting
    • Cervical High Grade Squamous Intraepithelial Lesion
    • +3 more
    • Breda, Netherlands
    • +12 more
    Jun 21, 2022

    Long-Term Follow-Up of HPV FOCAL Participants

    Active, not recruiting
    • Cervical Cancer
    • HPV and cytology co-testing (via Liquid based collection device)
    • Vancouver, British Columbia, Canada
      Women's Health Research Institute
    Oct 31, 2022

    Cervical Intraepithelial Neoplasia Grade 2, DNA Methylation Trial in Maribor (Testing DNA methylation test for predicting

    Recruiting
    • Cervical Intraepithelial Neoplasia Grade 2
    • DNA Methylation
    • Testing DNA methylation test for predicting prognosis of untreated CIN 2
    • Maribor, Slovenia
      University Medical Centre Maribor
    Nov 14, 2022

    Gastroparesis Trial in United States (CIN-102 Dose 1, CIN-102 Dose 2, CIN-102 Dose 3)

    Completed
    • Gastroparesis
    • CIN-102 Dose 1
    • +3 more
    • Chula Vista, California
    • +18 more
    Jul 16, 2021

    Irritable Bowel Syndrome With Diarrhea Trial (CIN-103, Placebo)

    Not yet recruiting
    • Irritable Bowel Syndrome With Diarrhea
    • (no location specified)
    Nov 22, 2023

    Cervical Cancer Screening With Human Papillomavirus Testing

    Recruiting
    • CIN3
    • +2 more
    • HPV screening
    • Buenos Aires, Argentina
    • +11 more
    Apr 1, 2022

    Papilloma Viral Infection, CIN1, LSIL, Low Grade Squamous Intraepithelial Lesion Trial in Madrid (Glizigen, Placebo)

    Recruiting
    • Papilloma Viral Infection
    • +2 more
    • Glizigen
    • Placebo
    • Madrid, Spain
    • +3 more
    Jun 27, 2023